Ocugen Inc Stock Buy Hold or Sell Recommendation
| OCGN Stock | USD 0.92 0.01 1.10% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Ocugen Inc is 'Strong Sell'. The recommendation algorithm takes into account all of Ocugen's available fundamental, technical, and predictive indicators you will find on this site.
Check out Ocugen Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Ocugen and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Ocugen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
Ocugen |
Execute Ocugen Buy or Sell Advice
The Ocugen recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Ocugen Inc. Macroaxis does not own or have any residual interests in Ocugen Inc or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Ocugen's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Dangerous | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Ocugen Trading Alerts and Improvement Suggestions
| Ocugen Inc generated a negative expected return over the last 90 days | |
| Ocugen Inc has some characteristics of a very speculative penny stock | |
| Ocugen Inc has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 6.04 M. Net Loss for the year was (63.08 M) with loss before overhead, payroll, taxes, and interest of (49.76 M). | |
| Ocugen Inc currently holds about 101.6 M in cash with (62.05 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.46. | |
| Ocugen Inc has a poor financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: Ocugen Announces European Medicines Agency Grants Orphan Medicinal Product Designation for Modifier Gene Therapy Candidate OCU410ST for Treatment ofABCA4-Associated Retinopathies including Stargardt Disease |
Ocugen Returns Distribution Density
The distribution of Ocugen's historical returns is an attempt to chart the uncertainty of Ocugen's future price movements. The chart of the probability distribution of Ocugen daily returns describes the distribution of returns around its average expected value. We use Ocugen Inc price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Ocugen returns is essential to provide solid investment advice for Ocugen.
| Mean Return | -0.44 | Value At Risk | -6.19 | Potential Upside | 8.08 | Standard Deviation | 4.11 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Ocugen historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Ocugen Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument, such as Ocugen, soars without any apparent reason. This usually happens because many institutional investors are aggressively trading Ocugen Inc back and forth among themselves. Companies that invest excess capital in these types of assets may also be included in this term and can influence corporate governance by exercising voting rights in their investments.
| Shares | Nuveen Asset Management, Llc | 2024-06-30 | 756.9 K | Bank Of New York Mellon Corp | 2024-06-30 | 751.8 K | Group One Trading, Lp | 2024-06-30 | 651.4 K | Bank Of America Corp | 2024-06-30 | 641.1 K | Susquehanna International Group, Llp | 2024-06-30 | 640.7 K | Ubs Group Ag | 2024-06-30 | 462.8 K | Two Sigma Investments Llc | 2024-09-30 | 363.7 K | Rhumbline Advisers | 2024-06-30 | 301.2 K | Barclays Plc | 2024-06-30 | 284.4 K | Blackrock Inc | 2024-06-30 | 17.9 M | Vanguard Group Inc | 2024-09-30 | 16.9 M |
Ocugen Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 5.8M | 16.6M | 70.9M | (17.5M) | (38.1M) | (36.2M) | |
| Free Cash Flow | (16.9M) | (15.0M) | (48.9M) | (64.5M) | (72.5M) | (68.9M) | |
| Depreciation | 60.6K | 102.1K | 229K | 480K | 704K | 585.1K | |
| Other Non Cash Items | 2.3M | 7.6M | 799K | 1.1M | 4.3M | 3.3M | |
| Capital Expenditures | 29.4K | 306.8K | 939K | 4.5M | 10.5M | 11.0M | |
| Net Income | (20.2M) | (21.8M) | (58.4M) | (81.4M) | (63.1M) | (59.9M) | |
| End Period Cash Flow | 7.6M | 24.2M | 95.1M | 77.6M | 39.5M | 37.7M | |
| Net Borrowings | 5.3M | (4.7M) | (10K) | 500K | 450K | 676.9K | |
| Change To Netincome | 5.8M | 8.2M | 7.7M | 11.6M | 13.3M | 14.0M | |
| Investments | (2.3M) | (306.8K) | (1.8M) | (17.0M) | 3.1M | 3.2M |
Ocugen Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Ocugen or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Ocugen's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Ocugen stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.68 | |
β | Beta against Dow Jones | 1.91 | |
σ | Overall volatility | 4.11 | |
Ir | Information ratio | -0.14 |
Ocugen Volatility Alert
Ocugen Inc exhibits very low volatility with skewness of 0.61 and kurtosis of 0.07. Ocugen Inc is a potential penny stock. Although Ocugen may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Ocugen Inc. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Ocugen instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Ocugen Fundamentals Vs Peers
Comparing Ocugen's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Ocugen's direct or indirect competition across all of the common fundamentals between Ocugen and the related equities. This way, we can detect undervalued stocks with similar characteristics as Ocugen or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Ocugen's fundamental indicators could also be used in its relative valuation, which is a method of valuing Ocugen by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Ocugen to competition |
| Fundamentals | Ocugen | Peer Average |
| Return On Equity | -1.03 | -0.31 |
| Return On Asset | -0.48 | -0.14 |
| Operating Margin | (11.67) % | (5.51) % |
| Current Valuation | 236.74 M | 16.62 B |
| Shares Outstanding | 291.32 M | 571.82 M |
| Shares Owned By Insiders | 1.39 % | 10.09 % |
| Shares Owned By Institutions | 27.52 % | 39.21 % |
| Number Of Shares Shorted | 50.65 M | 4.71 M |
| Price To Earning | (1.81) X | 28.72 X |
| Price To Book | 6.61 X | 9.51 X |
| Price To Sales | 57.16 X | 11.42 X |
| Revenue | 6.04 M | 9.43 B |
| Gross Profit | (49.76 M) | 27.38 B |
| EBITDA | (64.83 M) | 3.9 B |
| Net Income | (63.08 M) | 570.98 M |
| Cash And Equivalents | 101.6 M | 2.7 B |
| Cash Per Share | 0.46 X | 5.01 X |
| Total Debt | 6.94 M | 5.32 B |
| Debt To Equity | 0.07 % | 48.70 % |
| Current Ratio | 7.21 X | 2.16 X |
| Book Value Per Share | 0.16 X | 1.93 K |
| Cash Flow From Operations | (62.05 M) | 971.22 M |
| Short Ratio | 16.43 X | 4.00 X |
| Earnings Per Share | (0.19) X | 3.12 X |
| Target Price | 6.25 | |
| Number Of Employees | 65 | 18.84 K |
| Beta | 3.77 | -0.15 |
| Market Capitalization | 268.66 M | 19.03 B |
| Total Asset | 64.55 M | 29.47 B |
| Retained Earnings | (286.17 M) | 9.33 B |
| Working Capital | 25.88 M | 1.48 B |
| Current Asset | 17.53 M | 9.34 B |
| Current Liabilities | 4.21 M | 7.9 B |
Note: Acquisition by Musunuri Shankar of 100000 shares of Ocugen at 0.33 subject to Rule 16b-3 [view details]
Ocugen Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Ocugen . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Ocugen Buy or Sell Advice
When is the right time to buy or sell Ocugen Inc? Buying financial instruments such as Ocugen Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Ocugen in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Information Technology ETFs Thematic Idea Now
Information Technology ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Information Technology ETFs theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Information Technology ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Ocugen Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ocugen. If investors know Ocugen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ocugen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.19) | Revenue Per Share 0.018 | Quarterly Revenue Growth 1.353 | Return On Assets (0.48) | Return On Equity (1.03) |
The market value of Ocugen Inc is measured differently than its book value, which is the value of Ocugen that is recorded on the company's balance sheet. Investors also form their own opinion of Ocugen's value that differs from its market value or its book value, called intrinsic value, which is Ocugen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ocugen's market value can be influenced by many factors that don't directly affect Ocugen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ocugen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ocugen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ocugen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.